Filing Details

Accession Number:
0001466049-10-000112
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-22 16:26:50
Reporting Period:
2010-12-20
Filing Date:
2010-12-22
Accepted Time:
2010-12-22 16:26:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1322505 Biodel Inc BIOD Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304170 Solomon Steiner C/O Biodel Inc.
100 Saw Mill Road
Danbury CT 06810
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-12-20 67,633 $1.74 0 No 4 S Direct
Common Stock Disposition 2010-12-21 57,367 $1.77 3,986,899 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect See Footnote
Footnotes
  1. The amount shown excludes 3,986,899 shares of the Isser beneficially owned by Steiner Ventures, LLC. which shares may be deemed attributable to the Reporting Person because the Reporting Person is the sole managing member of Steiner Ventures, LLC. The Reporting Person disclaims beneificial ownership except to the extent of his pecuniary interest therein.
  2. This transaction was executed in multiple trades at prices ranging from $1.70 to 1.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The amount shown represents shares of the Issuer beneficially owned by Steiner Ventures, LLC. See Footenote 1.
  4. This transaction was executed in multiple trades at prices ranging from $1.75 to 1.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.